These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 6383926

  • 1. Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults.
    Gleichmann H, Zörcher B, Greulich B, Gries FA, Henrichs HR, Betrams J, Kolb H.
    Diabetologia; 1984 Jul; 27 Suppl():90-2. PubMed ID: 6383926
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cellular and humoural autoimmunity markers in type 2 (non-insulin-dependent) diabetic patients with secondary drug failure.
    Zavala AV, Fabiano de Bruno LE, Cardoso AI, Mota AH, Capucchio M, Poskus E, Fainboim L, Basabe JC.
    Diabetologia; 1992 Dec; 35(12):1159-64. PubMed ID: 1478368
    [Abstract] [Full Text] [Related]

  • 4. [HLA-antigens and islet cell antibodies in type-1 diabetics of various age groups and their first-degree relatives].
    Spinas GA, Keller U, Neri TM, Matter L, Staffelbach O, Berger W.
    Schweiz Med Wochenschr; 1985 Jan 12; 115(2):48-54. PubMed ID: 3881821
    [Abstract] [Full Text] [Related]

  • 5. Immunogenetic heterogeneity in type I (insulin-dependent) diabetes among the Tunisian population. HLA-DR antigens and organ-specific autoantibodies (family study).
    Jenhani F, Bardi R, Chammakhi S, Jeddi M, Ayed K.
    J Autoimmun; 1991 Jun 12; 4(3):553-61. PubMed ID: 1910427
    [Abstract] [Full Text] [Related]

  • 6. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
    Horton V, Stratton I, Bottazzo GF, Shattock M, Mackay I, Zimmet P, Manley S, Holman R, Turner R.
    Diabetologia; 1999 May 12; 42(5):608-16. PubMed ID: 10333055
    [Abstract] [Full Text] [Related]

  • 7. Islet cell antibodies and insulin autoantibodies in patients treated with oral hypoglycaemic agents.
    Jennings AM, Spencer KM, Dean BM, Wilson RM, Bottazzo GF, Ward JD.
    Diabet Med; 1989 Jul 12; 6(5):434-9. PubMed ID: 2527682
    [Abstract] [Full Text] [Related]

  • 8. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.
    Honeyman MC, Harrison LC, Drummond B, Colman PG, Tait BD.
    Mol Med; 1995 Jul 12; 1(5):576-82. PubMed ID: 8529124
    [Abstract] [Full Text] [Related]

  • 9. Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study.
    Thivolet C, Beaufrére B, Bétuel H, Gebuhrer L, Chatelain P, Durand A, Tourniaire J, François R.
    Diabetologia; 1988 Oct 12; 31(10):741-6. PubMed ID: 3071483
    [Abstract] [Full Text] [Related]

  • 10. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P, Külkey O, Luczay A, Bornemisza B, Illyés G, Halmos T, Baranyi E, Blatniczky L, Mészáros J, Kerényi Z, Geró L, Tamás G, Hosszúfalusi N, Horváth L, Madácsy L, Romics L.
    Orv Hetil; 1999 Nov 28; 140(48):2695-701. PubMed ID: 10645715
    [Abstract] [Full Text] [Related]

  • 11. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes.
    Ferber KM, Keller E, Albert ED, Ziegler AG.
    J Clin Endocrinol Metab; 1999 Jul 28; 84(7):2342-8. PubMed ID: 10404800
    [Abstract] [Full Text] [Related]

  • 12. The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method.
    Kobayashi T, Sugimoto T, Itoh T, Kosaka K, Tanaka T, Suwa S, Sato K, Tsuji K.
    Diabetes; 1986 Mar 28; 35(3):335-40. PubMed ID: 3512344
    [Abstract] [Full Text] [Related]

  • 13. The value of islet cell antibody in predicting secondary failure of oral hypoglycaemic agent therapy in Diabetes mellitus.
    Irvine WJ, Sawers JS, Feek CM, Prescott RJ, Duncan LJ.
    J Clin Lab Immunol; 1979 Apr 28; 2(1):23-6. PubMed ID: 95802
    [Abstract] [Full Text] [Related]

  • 14. Immune abnormalities in diabetic patients not requiring insulin at diagnosis.
    Di Mario U, Irvine WJ, Borsey DQ, Kyner JL, Weston J, Galfo C.
    Diabetologia; 1983 Nov 28; 25(5):392-5. PubMed ID: 6360778
    [Abstract] [Full Text] [Related]

  • 15. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study.
    Betterle C, Presotto F, Pedini B, Moro L, Slack RS, Zanette F, Zanchetta R.
    Diabetologia; 1987 May 28; 30(5):292-7. PubMed ID: 3301480
    [Abstract] [Full Text] [Related]

  • 16. Islet-cell cytoplasmic antibodies in Japanese diabetics.
    Shinjyo T, Hirata Y, Maruyama H, Ishiba S, Matuura N, Fukushima N, Wakisaka A.
    Tohoku J Exp Med; 1983 Dec 28; 141 Suppl():265-9. PubMed ID: 6393434
    [Abstract] [Full Text] [Related]

  • 17. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
    Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R.
    Lancet; 1997 Nov 01; 350(9087):1288-93. PubMed ID: 9357409
    [Abstract] [Full Text] [Related]

  • 18. Islet-cell antibodies (ICA-CFICA) and HLA genotypes in 107 IDD patients and their first-degree relatives.
    Deschamps I, Homberg JC, Janssen F, Lemut H, Vexiau P, Hors J.
    Hum Immunol; 1984 Jun 01; 10(2):129-34. PubMed ID: 6376432
    [Abstract] [Full Text] [Related]

  • 19. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM, Deschamps I, Garchon HJ, Roussely H, Moreau N, Beaurain G, Robert JJ, Bach JF.
    J Autoimmun; 1998 Dec 01; 11(6):643-50. PubMed ID: 9878086
    [Abstract] [Full Text] [Related]

  • 20. [Diabetes mellitus type I, thyroid gland autoimmunity, thyroid gland function and HLA status].
    Kehr S, Gastauer R, Winkler G.
    Monatsschr Kinderheilkd; 1985 Oct 01; 133(10):738-42. PubMed ID: 3906379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.